DEVICE INDUSTRY COMMENTS ON FDA ELECTRONIC SIGNATURE POLICY SOUGHT
This article was originally published in The Gray Sheet
Executive Summary
DEVICE INDUSTRY COMMENTS ON FDA ELECTRONIC SIGNATURE POLICY SOUGHT by the agency in an Aug. 31 Federal Register proposed rule. FDA specifically seeks comments from device manufacturers because of an erroneous belief that a July 21, 1992 advance notice of proposed rulemaking on electronic signatures only applied to pharmaceutical manufacturers, according to FDAers. Comments on the proposed rule are due by Nov. 29.
You may also be interested in...
Finance Watch: Canaan, Regeneron Reveal New Funds For Start-Ups
Private Company Edition: Regeneron launched a $500m venture fund and Canaan added $100m, bringing the venture firm’s recent total to $1bn-plus. Also, incubators plan to grow over the next decade and in recent financings Avenzo raised $150m and Nvelop launched with $100m.
Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.